Deutsche Bank
CERE

Deutsche Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Deutsche Bank’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,925
Closed -$242K – 3662
2024
Q2 		$242K Sell
5,925
-566,542
-99% -$23.6M ﹤0.01% 2699
2024
Q1 		$24.2M Buy
572,467
+210,053
+58% +$8.82M 0.01% 754
2023
Q4 		$15.4M Buy
362,414
+328,487
+968% +$9.44M 0.01% 861
2023
Q3 		$741K Buy
33,927
+4,599
+16% +$115K ﹤0.01% 1910
2023
Q2 		$932K Sell
29,328
-12,005
-29% -$368K ﹤0.01% 2031
2023
Q1 		$1.01M Buy
41,333
+11,535
+39% +$339K ﹤0.01% 2101
2022
Q4 		$940K Buy
29,798
+4,899
+20% +$138K ﹤0.01% 2098
2022
Q3 		$704K Sell
24,899
-7,288
-23% -$217K ﹤0.01% 2185
2022
Q2 		$850K Buy
32,187
+5,806
+22% +$165K ﹤0.01% 2282
2022
Q1 		$924K Sell
26,381
-1,963
-7% -$57.3K ﹤0.01% 2401
2021
Q4 		$919K Buy
28,344
+1,875
+7% +$66.2K ﹤0.01% 2484
2021
Q3 		$781K Buy
26,469
+4,021
+18% +$113K ﹤0.01% 2774
2021
Q2 		$575K Buy
+22,448
New +$321K ﹤0.01% 3132

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Deutsche Bank's CERE Position: Q3 2024 in Review

Deutsche Bank sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 5,925 shares — an estimated $242K sold.

Deutsche Bank first reported a position in CERE in Q2 2021 and held it in 13 quarters. The position peaked at $24.2M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Deutsche Bank reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Deutsche Bank sold 5,925 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $242K.
  • Deutsche Bank first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • Deutsche Bank's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $24.2M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Deutsche Bank's 13F filing for Q3 2024, filed 13 Nov 2024.